266 related articles for article (PubMed ID: 38279949)
1. The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease.
Björklund A; Barker RA
Brain; 2024 Jun; 147(6):1937-1952. PubMed ID: 38279949
[TBL] [Abstract][Full Text] [Related]
2. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
3. Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
Schumacher J; Kanel P; Dyrba M; Storch A; Bohnen NI; Teipel S; Grothe MJ
Brain; 2023 Dec; 146(12):4964-4973. PubMed ID: 37403733
[TBL] [Abstract][Full Text] [Related]
4. Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease.
Ray NJ; Lawson RA; Martin SL; Sigurdsson HP; Wilson J; Galna B; Lord S; Alcock L; Duncan GW; Khoo TK; O'Brien JT; Burn DJ; Taylor JP; Rea RC; Bergamino M; Rochester L; Yarnall AJ
Brain; 2023 Mar; 146(3):1053-1064. PubMed ID: 35485491
[TBL] [Abstract][Full Text] [Related]
5. Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
Crowley SJ; Kanel P; Roytman S; Bohnen NI; Hampstead BM
Brain; 2024 May; 147(5):1799-1808. PubMed ID: 38109781
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson's disease.
Berlot R; Pirtošek Z; Brezovar S; Koritnik B; Teipel SJ; Grothe MJ; Ray NJ
Brain Imaging Behav; 2022 Feb; 16(1):118-129. PubMed ID: 34176042
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
[TBL] [Abstract][Full Text] [Related]
8. Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson's disease and mild cognitive impairment.
Rea RC; Berlot R; Martin SL; Craig CE; Holmes PS; Wright DJ; Bon J; Pirtošek Z; Ray NJ
Neurobiol Aging; 2021 Oct; 106():37-44. PubMed ID: 34233212
[TBL] [Abstract][Full Text] [Related]
9. Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease.
Ray NJ; Kanel P; Bohnen NI
Ann Neurol; 2023 May; 93(5):991-998. PubMed ID: 36597786
[TBL] [Abstract][Full Text] [Related]
10. Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease.
Barrett MJ; Murphy JM; Zhang J; Blair JC; Flanigan JL; Nawaz H; Dalrymple WA; Sperling SA; Patrie J; Druzgal TJ
Parkinsonism Relat Disord; 2021 Sep; 90():27-32. PubMed ID: 34348192
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine modulates K
Coppi E; Cherchi F; Sarchielli E; Fusco I; Guarnieri G; Gallina P; Corradetti R; Pedata F; Vannelli GB; Pugliese AM; Morelli A
J Neurochem; 2021 May; 157(4):1182-1195. PubMed ID: 33030215
[TBL] [Abstract][Full Text] [Related]
12. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
13. Increase in cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction.
Llorente-Ovejero A; Manuel I; Giralt MT; Rodríguez-Puertas R
Neuroscience; 2017 Oct; 362():206-218. PubMed ID: 28827178
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O
Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376
[TBL] [Abstract][Full Text] [Related]
15. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
16. Spatial topography of the basal forebrain cholinergic projections: Organization and vulnerability to degeneration.
Schmitz TW; Zaborszky L
Handb Clin Neurol; 2021; 179():159-173. PubMed ID: 34225960
[TBL] [Abstract][Full Text] [Related]
17. Different cholinergic cell groups in the basal forebrain regulate social interaction and social recognition memory.
Okada K; Nishizawa K; Kobayashi T; Sakata S; Hashimoto K; Kobayashi K
Sci Rep; 2021 Jun; 11(1):13589. PubMed ID: 34193944
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease.
Wilson J; Yarnall AJ; Craig CE; Galna B; Lord S; Morris R; Lawson RA; Alcock L; Duncan GW; Khoo TK; O'Brien JT; Burn DJ; Taylor JP; Ray NJ; Rochester L
Mov Disord; 2021 Mar; 36(3):611-621. PubMed ID: 33382126
[TBL] [Abstract][Full Text] [Related]
19. Basal Forebrain Cholinergic Deficits Reduce Glucose Metabolism and Function of Cholinergic and GABAergic Systems in the Cingulate Cortex.
Jeong DU; Oh JH; Lee JE; Lee J; Cho ZH; Chang JW; Chang WS
Yonsei Med J; 2016 Jan; 57(1):165-72. PubMed ID: 26632397
[TBL] [Abstract][Full Text] [Related]
20. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
